The first Rare Disease Day was celebrated in 2008 on 29 February, a ‘rare’ date that happens only once every four years. Ever since then, Rare Disease Day has taken place on the last day of February, a month known for having a ‘rare’ number of days. In Europe, a disease is
News and views about Coremine Vitae and personalised healthcare.
Many people who are navigating cancer information, or love someone who is, are using the internet to find information about their symptoms, diagnosis, prognosis, treatments, and lifestyle advice – often causing more anxiety than relief. Did you know cyberchondria refers to a person’s anxiety about their health that is created or exacerbated
Though 2020 was a challenging year for all of us, there were some good news for many cancer patients. In oncology, the U.S. Food and Drug Administration (FDA) granted approval to several novel drugs and new indications for older therapeutic agents. According to the FDA’s count, it approved as many as 53 new molecular entities in
We are proud to announce that our digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, testament of the quality and compliance with all the health, safety, cybersecurity, and performance required by the European legislation. Finding personalized treatment options Coremine Vitae is intended to aid in the personalised and shared clinical decision. It is indicated for patients with
Jimita joined PubGene to work in the Coremine Vitae’s Case Analysis team where she analyses patient cases, identifies treatment options and conducts research. As both a Pharmacist and PhD in Medicine, her background is a perfect complement to the team. Learn more about Jimita, her expectations for joining the team and her experience so
Here is a quick roundup of the great pieces we’ve been reading lately: Men and women are obviously biologically different. Yet, “for decades medicine has worked on the basis that we are fundamentally the same. Remarkably, many of the drugs we commonly use have been trialled almost exclusively on males.” Check out